[Menkes disease]

R Simkó1, B Lombay, I Velkey

  • 1Borsod-Abaúj-Zemplén Megyei Kórház-Rendelöintézet, Miskolc.

Orvosi Hetilap
|December 25, 1994
PubMed

Insights

Menkes disease, a rare X-linked copper metabolism disorder, causes severe neurological damage and is lethal in early childhood. This summary covers its diagnosis, pathogenesis, and therapeutic approaches.

Area of Science:

  • Genetics and Metabolic Disorders
  • Neuroscience

Background:

  • Menkes disease is a rare, X-linked genetic disorder affecting copper transport.
  • It leads to systemic copper deficiency, impacting multiple organs.

Observation:

  • The disease is characterized by severe neurological degeneration, particularly affecting the brain and cerebellum.
  • Clinical presentation includes kinky hair, failure to thrive, and developmental delay.

Findings:

  • Diagnosis relies on clinical findings, biochemical assays for copper levels, and genetic testing.
  • Pathogenesis involves mutations in the ATP7A gene, disrupting copper homeostasis.
  • Current therapeutic strategies are limited, focusing on copper supplementation with variable efficacy.

Implications:

  • Early diagnosis and intervention are crucial for potentially mitigating severe outcomes.
  • Further research into novel therapeutic targets is warranted.
  • Understanding copper metabolism is vital for treating Menkes disease and related disorders.

Related Concept Videos

Meiosis I01:49

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by a...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Meiosis I03:09

Meiosis I

Meiosis is the division of a diploid cell into haploid cells forming sperm and eggs in animals through differentiation. Meiosis I is the first stage of meiosis, where the genetic recombination of homologous chromosomes and the reduction of the ploidy level by half occurs.
Prophase I is the most extended and complex step of meiosis I characterized by synapsis, chromosome pairing, and recombination of the homologous chromosomes. This process is facilitated by a proteinaceous structure called the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...